$2.57 Million Elementis Penalty Reversed In Decision on Hexavalent Chromium Study

A $2.57 million fine against Elementis Chromium Inc. has been reversed by a final order by the Environmental Protection Agency’s Environmental Appeals Board (In re Elementis Cromium Inc.).

Elementis was not required to submit a study that showed workers exposed to hexavalent chromium faced an increased risk of lung cancer, because the agency already knew that lung cancer could result at a lower cumulative dose, the board said in an order posted online March 16.

Chemical manufacturers are required to file adverse effects information, known as substantial risk notifications, when the information pertains to a previously unknown effect ...